The Korean Journal of Rehabilitation Nursing (재활간호학회지)

Korean Academic Society of Rehabilitation Nursing (한국재활간호학회)
권호 표지

Tingling Sensation and Difficulty in Daily Living of Clients Treated FOLFOX Chemotherapy after Colon Resection

FOLFOX 항암화학요법을 받는 대상자의 저림감과 일상생활 어려움

  • Received : 2010.04.29
  • Accepted : 2010.09.20
  • Published : 2010.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: This study was to investigate difficulties in daily activities and tingling from patients having treatment of FOLFOX chemotherapy after colon resection. Method: This study included 103 patients hospitalized for FOLFOX chemotherapy in one of the university affiliated hospital from August 1, 2008 through September 30, 2009. Data were collected using the questionnaire comprised general symptoms, tingling, difficulties in daily activities and coping behavior. Using the SPSS 14.0 program, data analytic methods include Chi-Square test, ANOVA, Scheffe's test. Results: The tingling sensation occurred in hands, feet, mouth, throat. Contacts with cold objects and the number of chemotherapy cycle worsen tingling sensation. Patients experienced difficulties in daily activities such as personal hygiene, kitchen work, eating cold food, sleeping cold, using fine motors like button up, writing, or using knife. The coping behavior included drinking warm water, sleeping warm, using gloves and socks, wearing comfortable shoes, massaging hands and getting help from supporters. Conclusion: An educational guideline for promoting coping behavior to relieve tingling sensation and difficulty in daily living in patients with FOLFOX chemotherapy is needed.

Keywords

References

  1. An, B. M. (2005). Outpatient basis chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as first-line treatment for patients with metastatic or recurrent colorectal cancer. Unpublished master's thesis, Kyungpook National University, Daegu.
  2. Bang, S. M., Cho, E. K., Oh, J. H., Chang, H. M., Ahn, J. S., & Rhee, J. A., et al. (2001). Combination chemotheapy of oxaliplatin, 5-fluorouracil, and leucovorin in 5-fluorouracil-pretreated patients with metastatic colorectal cancer. Journal of Korean Cancer Research Association, 33, 414-419.
  3. De Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., & Cassidy, J., et al. (2000). Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. Journal of Clinical Oncology, 18, 2938-2947.
  4. Gamelin, L., Boisdron-Celle, M., Morel, A., Poirier, A. L., Berger, V., & Gamelin, E., et al. (2008). Oxaliplatinrelated neurotoxicity: Interest of calcium-magnesium infusion and no impact on its efficacy. Journal of Clinical Oncology, 26, 1189-1190.
  5. Giacchetti, S., Perpoint, B., Zidani, R., Le Bail, N., Faggiuolo, R., & Focan, C., et al. (2000). Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. Journal of Clinical Oncology, 18, 136-147.
  6. Hong, G. P., Kang, H. S., Oh, S. Y., Im, N. Y., Kim, J. I., & Yoo, M. S., et al. (2000). Basic nursing II. Seoul: Soomoonsa.
  7. Kim, H. J. (1997). Cancer patients' use of self-care behaviors in managing side effects related to chemotherapy. Unpublished master's thesis, Chung-Ang University, Seoul.
  8. Kim, J. E. (2009). The family support and the management of side effects from chemotherapy for female cancer patients. Unpublished master's thesis, Ewha Womans University, Seoul.
  9. Kim, M. J. (2007). Side effects and coping methods in patients receiving chemotherapy for treatment of stomach cancer. Unpublished master's thesis, Hanyang University, Seoul.
  10. Kim, Y. J., & Kim, H. D. (2004). New trend in chemotherapy for colorectal cancer. Journal of the Korean Society of Coloproctology, 20, 118-123.
  11. Kim, Y. K. (2007). Side effects of chemotherapy for gastrointestinal cancer patients who visited in ER. Unpublished master's thesis, Ewha Womans University, Seoul.
  12. Lee, J. E. (2005). Symptom experiences according to chemotherapy cycle in patients with breast cancer. Unpublished master's thesis, Yonsei University, Seoul.
  13. Lee, J. H., Park, S. J., Park, S. E., Kwak, S. K., Shin, H. Y., & Kim, S. E., et al. (2001). The efficacy of combination chemotherapy of 5-fluorouracil, leucovorin, oxaliplatin, on relapsed or refractory colorectal cancer. Chungnam Medical Journal, 28, 277-287.
  14. Lee, M. R. (2006). The effects of personal education on prevention of oral mucositis and self care performance for cancer patients receiving cancer chemotherapy. Unpublished master's thesis, Yonsei University, Seoul.
  15. McCorkle, R., & Young, K. (1978). Development of a symptom distress scale. Cancer Nursing, 1, 373-378.
  16. Park, M. H. (2003). Analysis of Oxaliplatin and Irinotecan combined with Fluorouracil as second-line treatment in patient with progressive, metastatic coloretal cancer after 5-FU regimen failure. Unpublished master's thesis, Sookmyung Women's University, Seoul.
  17. Park, Y. S. (2007). Recent advances in treatment of colon cancer. Journal of the Korean Academy of Family Medicine, 28, 302-305.
  18. Raymond, E., Chaney, S. G., Taamma, A., & Cvitkovic, E. (1998). Oxaliplatin: A review of preclinical and clinical studies. Annals of Oncology, 9, 1053-1071. https://doi.org/10.1023/A:1008213732429
  19. Saif, M. W., & Reardon, J. (2005) Management of oxaliplatininduced peripheral neuropathy. Therapeutics and Clinical Risk Management, 1, 249-258.
  20. Shin, J. H., Kim, S. Y., Woo, C. M., Kim, Y. S., Kim, J. Y., & Seo, J. H., et al. (2004). Oxaliplatin and UFT, leucovorin combination chemotherapy in patients with advanced colorectal cancer. Korean Journal of Medicine, 67, 58-64.
  21. Statistics Korea. (2009). Cause of death. Retrieved October 21, 2009, from http://www.kostat.go.kr/
  22. Suh, C. W., Kim, S. Y., Bang, Y. J., Kim, N. K., Park, J. G., & Lee, K. U., et al. (1988). 5-Fluorouracil infusion and Cisplatin (FP) combination chemotherapy for metastatic or recurrent colorectal cancer. Korean Journal of Medicine, 35, 464-470.
  23. Wiseman, L. R., Adkins, J. C., Plosker, G. L., & Goa, K. L. (1999). Oxaliplatin: A review of its use in the management of metastatic colorectal cancer. Drugs & Aging, 14, 459-475. https://doi.org/10.2165/00002512-199914060-00006
  24. Yu, S. M., & Gu, M. O. (2003). A study on nausea & vomiting, anorexia and food intake in cancer patients undergoing chemotherapy overtime. Journal of Korean Academy of Adult Nursing, 15, 573-585.